TILMODIL 300 Injection

Tilmodil Product Leaflet Nov19_imag... .pdf

For use in lot-fed cattle for the treatment of Bovine Respiratory Disease (BRD) associated with Mannheimia (Pasteurella) haemolytica, Pasteurella multocida, and other organisms susceptible to tilmicosin.

PRODUCT CODE

MINIMUM

Composition

ACTIVE CONSTITUENT: 300 mg/mL TILMICOSIN

Directions for Use

Dosage and Administration

Administer a single subcutaneous injection of 10 mg tilmicosin/kg bodyweight (1mL per 30kg), using a standard disposable syringe or multi-filling syringe. With a single hand on the syringe, insert the needle subcutaneously, at a top-down angle, whilst avoiding penetration of underlying muscle. Do not inject more than 25mL per injection site. Subcutaneous injection must be made high into the neck. If no improvement is noted within 48 hours the diagnosis should be re-evaluated.

Single dose only.

NOTE: Swelling at the subcutaneous site of injection may be observed but is transient and usually mild.

Withholding Period

WITHHOLDING PERIODS

MEAT - DO NOT USE less than 28 days before slaughter for human consumption.
MILK - DO NOT USE in lactating cows where milk may be used or processed for human consumption.

Any variation by the prescribing veterinarian to the approved dose, frequency, duration, route, disease, or target species may require extending the approved withholding period.

TRADE ADVICE
EXPORT SLAUGHTER INTERVAL (ESI): DO NOT USE less than 42 days before slaughter for export. Before using this product, confirm the current ESI from Abbey Animal Health Pty Ltd on (02) 8088 0720 or the APVMA website (www.apvma.gov.au/residues).

Pack Size

250mL